Pas de connexion internet — affichage de la version enregistrée de la page.

Amgen Inc

USUSD
← Vers le screener

Amgen Inc (US:AMGN) — Biotechnology: Biological Products (No Diagnostic Substances). Nombre de places boursières sur lesquelles les actions de la société sont cotées : 4. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.

À propos de l'entreprise

Site web
amgen.com
Relations avec les investisseurs
investors.amgen.com/
Secteur
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Siège social
Thousand Oaks, United States
PDG
Robert A. Bradway
Employés
17 900
Fondée
1980
Actions en circulation
540.63 M au 2026-07-30
Flottant
539.16 M
Capitalisation boursière
226.05 Md USD
Initiés
0.23%
Investisseurs institutionnels
85.02%
Secteur d'activité (SIC)
Biological Products, (No Diagnostic Substances)
Forme juridique
XTIQ
ISIN
US0311621009
LEI
62QBXGPJ34PQ72Z12S66
Taux de distribution
60.4%
FCF
10.2 Md USD
52%
Dette
57.3 Md USD
4.3 ans de FCF
Ancienneté du dividende
15 ans
Bénéfices, FCF et dividendes versés — pour les 12 mois précédant 30.06.2026 (le dernier rapport de l'entreprise).
Description

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Bourses et tickers

BourseTickerDevisePrixType
US USA StocksAMGN principaleUSD407.44 -1.37%actions ordinaires
HK Hong Kong Stock Exchange4332 secondaireHKD—
LSE London Stock Exchange0R0T IOBUSD411.854 +1.17%actions ordinaires
MX Mexican Stock ExchangeAMGN secondaireMXN7 500.0098 +0.00%actions ordinaires
XETRA XetraAMG secondaireEUR367.95 -1.39%actions ordinaires

Cours sur 3 mois

jour de hausse jour de baisse date de détachement du dividende date de versementSurvolez / touchez un jour — cours d'ouverture, de clôture, plus haut et plus bas

Dividendes

12 derniers mois, US:AMGN: 9.94 USD (4 vers.)

Amgen Inc (AMGN) verse des dividendes trimestriels. Au cours des 12 derniers mois, 9.94 USD par action ont été versés (versements : 4). Cela représente environ 2.44% du cours actuel de l'action. D'après l'historique des paiements, la prochaine date ex-dividende est prévue vers 20.11.2026. Historique des dividendes ininterrompu : 15 ans.

Date exVersementMontant%TypeTicker
2026-08-212026-09-112.5200 USD0.6/2.4 %trimestrielUS:AMGN
2026-05-152026-06-052.5200 USD0.6/2.4 %trimestrielUS:AMGN
2026-02-132026-03-062.5200 USD0.6/2.4 %trimestrielUS:AMGN
2025-11-212025-12-122.3800 USD0.6/2.3 %trimestrielUS:AMGN
2025-08-222025-09-122.3800 USD0.6/2.3 %trimestrielUS:AMGN
2025-05-162025-06-062.3800 USD0.6/≈2.3 %trimestrielUS:AMGN
2025-02-142025-03-072.3800 USD0.6/≈2.3 %trimestrielUS:AMGN
2024-11-182024-12-092.2500 USD0.6/≈2.2 %trimestrielUS:AMGN

Actualités de cette semaine

Pas encore d'actualités du site de l'entreprise.

publicité

Principaux actionnaires

DétenteurParticipationActionsDate du rapport
Blackrock Inc.9.13%49.36 M2026-06-30
Vanguard Capital Managem…6.52%35.25 M2026-06-30
State Street Corporation5.65%30.56 M2026-06-30
Capital World Investors5.38%29.08 M2026-06-30
VANGUARD INDEX FUNDS-Van…3.17%17.13 M2026-06-30
Invesco Ltd.3.02%16.32 M2026-06-30
Geode Capital Management…2.9%15.7 M2026-06-30
Charles Schwab Investmen…2.78%15.03 M2026-06-30
Vanguard Portfolio Manag…2.75%14.85 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.59%13.99 M2026-06-30
Morgan Stanley2.53%13.65 M2026-06-30
Invesco QQQ Trust, Serie…2.15%11.61 M2026-08-31
SCHWAB STRATEGIC TRUST-S…1.81%9.79 M2026-05-31
Income Fund of America1.44%7.76 M2026-06-30
iShares Trust-iShares Co…1.35%7.28 M2026-07-31
Wells Fargo & Company1.34%7.24 M2026-06-30
AMERICAN BALANCED FUND1.31%7.09 M2026-06-30
Fidelity Concord Street…1.29%6.98 M2026-07-31
SPDR S&P 500 ETF TRUST-S…1.22%6.6 M2026-08-31
WASHINGTON MUTUAL INVEST…1.16%6.27 M2026-06-30
BRADWAY ROBERT A (Chief…≈0.12%657 2992026-05-05
SANTOS ESTEBAN (Officer)≈0.02%84 2792026-05-05
GORDON MURDO (Officer)≈0.01%51 8372026-05-05
GRIFFITH PETER H. (Chief…≈0.01%50 7062026-05-05
REESE DAVID M. (Chief Te…≈0.01%42 8122026-05-05
GRAHAM JONATHAN P (Gener…≈0.01%40 2112026-05-05
BRADNER JAMES E. (Office…≈0.01%30 4622026-05-05
ECKERT ROBERT ANDREW (Di…≈0%26 2512026-05-19
JACKS TYLER (Director)≈0%18 2842026-05-19
KULLMAN ELLEN JAMISON (D…≈0%14 5362026-05-19